RayKnowChina Research Map
Shortlist

BeijingCapital Medical University

Beijing Anzhen Hospital

首都医科大学附属北京安贞医院

Listed for 13 of the 53 diseases this site covers, from the research papers it led and the trials registered with it as lead sponsor or site.

Research activity in public records, not a rating of care. Whether the hospital can help a particular patient is for the hospital and the treating doctor to say.

No official website checked for this hospital yet.

Getting in touch

Research at Beijing Anzhen Hospital

Choose a disease to see the papers and trials behind it. Each tile shows papers led, 2021–2025, and papers per year.

Only the 53 diseases this site covers. A disease it is not listed for means this hospital did not meet the listing rule for that disease in these records; it does not mean the hospital does not treat it. Which hospitals are listed

  1. Oesophageal squamous cell carcinoma食管鳞状细胞癌6 papers led
  2. Osteosarcoma骨肉瘤1 paper led
  3. Gastrointestinal stromal tumour胃肠道间质瘤0 papers led
  4. Haemophagocytic lymphohistiocytosis噬血细胞性淋巴组织细胞增生症2 papers led
  5. Beta thalassaemiaβ 地中海贫血0 papers led
  6. IgG4-related diseaseIgG4相关性疾病0 papers led
  7. Takayasu arteritis大动脉炎30 papers led
  8. Idiopathic pulmonary fibrosis特发性肺纤维化1 paper led
  9. Fabry disease法布雷病0 papers led
  10. Behçet disease白塞病2 papers led
  11. Alport syndromeAlport 综合征1 paper led
  12. IgA nephropathyIgA 肾病3 papers led
  13. Primary biliary cholangitis原发性胆汁性胆管炎1 paper led

Not listed for: Nasopharyngeal carcinoma, Hepatocellular carcinoma, Stomach cancer, Hepatoblastoma, Retinoblastoma, Chordoma, Neuroblastoma, Ewing sarcoma, Multiple myeloma, B-cell acute lymphoblastic leukaemia, Aplastic anaemia, Haemophilia A, Atypical haemolytic uraemic syndrome, Thrombotic thrombocytopenic purpura, Fanconi anaemia, Neuromyelitis optica spectrum disorder, Myasthenia gravis, Moyamoya disease, Wilson disease, Biliary atresia, Anti-NMDA receptor encephalitis, Hepatic echinococcosis, Lymphangioleiomyomatosis, Amyotrophic lateral sclerosis, Spinal muscular atrophy, Pompe disease, Duchenne muscular dystrophy, Gaucher disease, Niemann–Pick disease type C, Osteogenesis imperfecta, Primary sclerosing cholangitis, Congenital diaphragmatic hernia, Hirschsprung disease, Inherited epidermolysis bullosa, Hereditary angioedema, Familial adenomatous polyposis, Leber hereditary optic neuropathy, Majeed syndrome, NGLY1 deficiency, ISG15 deficiency.

Cancer

Oesophageal squamous cell carcinoma

食管鳞状细胞癌

Led 6 of the 2,923 English-language PubMed papers on oesophageal squamous cell carcinoma with an author in mainland China, 2021–2025: 0.2%.

Papers led
6
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 1120242025: 552025

12 hospitals in Beijing for oesophageal squamous cell carcinoma192 hospitals in China for oesophageal squamous cell carcinoma

No open trial on oesophageal squamous cell carcinoma lists this hospital on ClinicalTrials.gov on 8 Nov 2026.

The records behind these numbers
ThemesMolecular markers & genomics
Departments in papersMedical oncology

Over half of these papers are lab or animal studies.

Run the PubMed searchClinicalTrials.gov

Cancer

Osteosarcoma

骨肉瘤

Led 1 of the 2,257 English-language PubMed papers on osteosarcoma with an author in mainland China, 2021–2025: 0.04%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 1120222023: 0020232024: 0020242025: 002025

37 hospitals in Beijing for osteosarcoma570 hospitals in China for osteosarcoma

No open trial on osteosarcoma lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersRadiology / nuclear medicine

Run the PubMed searchClinicalTrials.gov

Cancer

Gastrointestinal stromal tumour

胃肠道间质瘤

Led no English-language PubMed papers on gastrointestinal stromal tumour in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution

19 hospitals in Beijing for gastrointestinal stromal tumour240 hospitals in China for gastrointestinal stromal tumour

No open trial on gastrointestinal stromal tumour lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersPathology / laboratory medicine
Chinese-language papers (not in the count)1
  1. [Gastrointestinal stromal tumor with right ventricle metastases: report of a case].2022Zhonghua bing li xue za zhi = Chinese journal of pathology

Run the PubMed searchClinicalTrials.gov

Blood disorders

Haemophagocytic lymphohistiocytosis

噬血细胞性淋巴组织细胞增生症

Led 2 of the 399 English-language PubMed papers on haemophagocytic lymphohistiocytosis with an author in mainland China, 2021–2025: 0.5%.

Papers led
2
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 0020242025: 222025

11 hospitals in Beijing for haemophagocytic lymphohistiocytosis66 hospitals in China for haemophagocytic lymphohistiocytosis

No open trial on haemophagocytic lymphohistiocytosis lists this hospital on ClinicalTrials.gov on 8 Nov 2026.

The records behind these numbers
ThemesTreatment regimensLymphoma & cancer-related HLHGenetics & inherited forms

Run the PubMed searchClinicalTrials.gov

Blood disorders

Beta thalassaemia

β 地中海贫血

Led no English-language PubMed papers on beta thalassaemia in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution

10 hospitals in Beijing for beta thalassaemia133 hospitals in China for beta thalassaemia

No open trial on beta thalassaemia lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersPathology / laboratory medicine
Chinese-language papers (not in the count)1
  1. [Analysis of Gene Types and Clinical Characteristics of Thalassemia in Children in Nanchong Area].2025Zhongguo shi yan xue ye xue za zhi

Run the PubMed searchClinicalTrials.gov

Other diseases

IgG4-related disease

IgG4相关性疾病

Led no English-language PubMed papers on IgG4-related disease in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution

11 hospitals in Beijing for IgG4-related disease46 hospitals in China for IgG4-related disease

No open trial on IgG4-related disease lists this hospital on ClinicalTrials.gov on 8 Nov 2026.

The records behind these numbers

Run the PubMed searchClinicalTrials.gov

Other diseases

Takayasu arteritis

大动脉炎

Led 30 of the 187 English-language PubMed papers on Takayasu arteritis with an author in mainland China, 2021–2025: 16.0%.

Papers led
30
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
1
led by another institution
Papers led per year
2021: 5520212022: 7720222023: 8820232024: 3320242025: 662025

24 hospitals in Beijing for Takayasu arteritis100 hospitals in China for Takayasu arteritis

Open trials with this hospital 1

Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 13 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.

  1. Recruiting
    A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA)
    Phase
    Not given
    Started
    2016-01
    Registry
    NCT03372980

    Age 18 years to 70 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

The records behind these numbers
Departments in papersRheumatology & immunologyPathology / laboratory medicineRadiology / nuclear medicine
Papers it led30
  1. ANK2-MAVS signaling dysfunction triggers mitochondrial stress and enhances IL-8 mediated inflammatory responses in Takayasu arteritis.2026Free radical biology & medicine
  2. Integrated bulk and single-cell transcriptomics identifies shared and specific immune signatures in Takayasu Arteritis.2025Arthritis research & therapy
  3. Single-cell transcriptome analysis reveals cellular heterogeneity in the aortas of Takayasu arteritis.2025Arthritis research & therapy
  4. Acute left heart failure is the initial manifestation of Takayasu arteritis: a case report.2025BMC cardiovascular disorders
  5. CD8 cell-derived granzyme B may be a predictor for coronary artery involvement and MACE in Takayasu arteritis patients.2025Clinical and experimental immunology
  6. Elevated serum uric acid is a predictor of pulmonary artery involvement and subsequent prognosis in patients with Takayasu's arteritis.2025Clinical and experimental rheumatology
  7. The role of granulocyte colony-stimulating factor in Takayasu arteritis.2025Clinical rheumatology
  8. Coronary artery calcification in Takayasu's arteritis: clinical characteristics and risk factors.2024Clinical and experimental rheumatology
  9. Elevated serum 25-hydroxyvitamin D: a potential indicator of remission in Takayasu arteritis patients with normal ESR and CRP levels.2024Clinical rheumatology
  10. Right Ventricular Function in Takayasu's Arteritis Patients With Pulmonary Artery Involvement Using MRI Feature Tracking.2024Journal of magnetic resonance imaging : JMRI
  11. Elevated serum immunoglobulin level predicts high risk of 1-year recurrence in patients with Takayasu arteritis.2023Arthritis research & therapy
  12. Predictors for pulmonary artery involvement in Takayasu arteritis and its cluster analysis.2023Arthritis research & therapy
  13. PD-1 Deficiency in Regulatory T Cells May be Involved in the Pathogenesis of Takayasu's Arteritis.2023Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  14. Characteristics of B cells and immunoglobulin profile in Takayasu's arteritis.2023Clinical and experimental rheumatology
  15. High-throughput sequencing reveals the change of TCR α chain CDR3 with Takayasu arteritis.2023Immunity, inflammation and disease
  16. Biomarkers in Takayasu arteritis.2023International journal of cardiology
  17. Anaemia can be improved by controlling the disease activity of Takayasu's arteritis without iron administration.2023International journal of laboratory hematology
  18. Platelet count as a potential predictor in refractory Takayasu arteritis.2023Rheumatology international
  19. Risk factors and surgical prognosis in patients with aortic valve involvement caused by Takayasu arteritis.2022Arthritis research & therapy
  20. Five-year outcome with revascularisation therapy in Takayasu arteritis with multiple coronary involvement: a case review.2022Cardiology in the young
  21. Association of Prolonged Disease Duration and TG/HDL-C Ratio in Accelerating Atherosclerosis in Patients with Takayasu's Arteritis.2022Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  22. Clinical features and risk factors of intracranial artery disease in patients with Takayasu arteritis.2022Clinical rheumatology
  23. The role of CD8+ Granzyme B+ T cells in the pathogenesis of Takayasu's arteritis.2022Clinical rheumatology
  24. Male Patients with Takayasu Arteritis and Coronary Artery Involvement are Prone to Have Serious Coronary Stenosis and High Mortality.2022Current vascular pharmacology
  25. Quantification of Myocardial Deformation in Patients with Takayasu Arteritis by Cardiovascular Magnetic Resonance Feature Tracking Imaging.2022Journal of magnetic resonance imaging : JMRI
  26. Plasma proteomic screening and validation of novel biomarkers in Takayasu's arteritis.2021Clinical and experimental rheumatology
  27. Cardiac valvular involvement of Takayasu arteritis.2021Clinical rheumatology
  28. Pulmonary artery involvement in Takayasu arteritis: a retrospective study in Chinese population.2021Clinical rheumatology
  29. Serum concentrations of small dense low-density lipoprotein cholesterol and lipoprotein(a) are related to coronary arteriostenosis in Takayasu arteritis.2021Journal of clinical laboratory analysis
  30. CD8+ T lymphocyte is a main source of interferon-gamma production in Takayasu's arteritis.2021Scientific reports
Chinese-language papers (not in the count)1
  1. [Preliminary Results of Single-cell Transcriptome Sequencing in Renal Arterial Lesions of Takayasu Arteritis].2023Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
Earlier papers (2016–2020)19
  1. Elevated antistreptolysin O titer is closely related to cardiac mitral insufficiency in untreated patients with Takayasu arteritis.2020BMC cardiovascular disorders
  2. Association of interleukin-18 gene polymorphisms with Takayasu arteritis in a Chinese Han population.2020Chinese medical journal
  3. Natural killer cells and their function in Takayasu's arteritis.2020Clinical and experimental rheumatology
  4. Contribution of Th2-like Treg cells to the pathogenesis of Takayasu's arteritis.2020Clinical and experimental rheumatology
  5. Numano type V Takayasu arteritis patients are more prone to have coronary artery involvement.2020Clinical rheumatology
  6. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.2020Clinical rheumatology
  7. Comparison of Clinical Features at the Onset of Takayasu's Arteritis According to Age and Sex.2020Current vascular pharmacology
  8. The relationships of serum homocysteine levels and traditional lipid indicators with disease activity and coronary artery involvement in Takayasu arteritis.2020Immunologic research
  9. T-614 inhibits human aortic adventitial fibroblast proliferation and promotes interleukin-8 production in vitro.2020Vascular
  10. [Clinical features of intracranial vessel involvement in Takayasu's arteritis].2020Zhonghua yi xue za zhi
  11. Treatment with Corticosteroid and/or Immunosuppressive Agents before Surgery can Effectively Improve the Surgical Outcome in Patients with Takayasu's Arteritis.2019Journal of investigative surgery : the official journal of the Academy of Surgical Research
  12. Takayasu Arteritis with Dyslipidemia Increases Risk of Aneurysm.2019Scientific reports
  13. [Efficacy and safety of tocilizumab in patients with Takayasu arteritis].2019Zhonghua nei ke za zhi
  14. [Relationships between the levels of serum 25-hydroxyvitamin D and interleukin-6 in patients with Takayasu's arteritis].2018Zhonghua yi xue za zhi
  15. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu's arteritis: a case-control study.2017BMJ open
  16. Relationship of HLA-B*51 and HLA-B*52 alleles and TNF-α-308A/G polymorphism with susceptibility to Takayasu arteritis: a meta-analysis.2017Clinical rheumatology
  17. IL-9-producing Th9 cells may participate in pathogenesis of Takayasu's arteritis.2016Clinical rheumatology
  18. Sonographic Characterization of Arterial Dissections in Takayasu Arteritis.2016Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
  19. [Clinical data analysis of valvular involvement in Takayasu arteritis].2016Zhonghua yi xue za zhi
All its trials on ClinicalTrials.gov, any status4
  1. A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA)RecruitingNCT03372980Study siteStart 2016-01
  2. Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's ArteritisNot yet recruitingNCT07451665Study sitePhase 4Start 2026-04
  3. Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu ArteritisStatus unknownNCT05151848Study sitePhase 4Start 2022-01
  4. Takayasu Arteritis Clinical Trial in ChinaCompletedNCT02981979Study siteN/AStart 2016-12

Run the PubMed searchClinicalTrials.gov

Other diseases

Idiopathic pulmonary fibrosis

特发性肺纤维化

Led 1 of the 989 English-language PubMed papers on idiopathic pulmonary fibrosis with an author in mainland China, 2021–2025: 0.1%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 1120222023: 0020232024: 0020242025: 002025

25 hospitals in Beijing for idiopathic pulmonary fibrosis288 hospitals in China for idiopathic pulmonary fibrosis

No open trial on idiopathic pulmonary fibrosis lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Run the PubMed searchClinicalTrials.gov

Other diseases

Fabry disease

法布雷病

Led no English-language PubMed papers on Fabry disease in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution

9 hospitals in Beijing for Fabry disease80 hospitals in China for Fabry disease

No open trial on Fabry disease lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersRadiology / nuclear medicine
Chinese-language papers (not in the count)1
  1. [Clinical manifestation and genetic analysis of a family with Fabry disease].2025Zhonghua xin xue guan bing za zhi

Run the PubMed searchClinicalTrials.gov

Other diseases

Behçet disease

白塞病

Led 2 of the 245 English-language PubMed papers on Behçet disease with an author in mainland China, 2021–2025: 0.8%.

Papers led
2
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 1120232024: 0020242025: 112025

19 hospitals in Beijing for Behçet disease139 hospitals in China for Behçet disease

No open trial on Behçet disease lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersRheumatology & immunologyRadiology / nuclear medicine

Run the PubMed searchClinicalTrials.gov

Other diseases

Alport syndrome

Alport 综合征

Led 1 of the 58 English-language PubMed papers on Alport syndrome with an author in mainland China, 2021–2025: 1.7%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 1120232024: 0020242025: 002025

7 hospitals in Beijing for Alport syndrome60 hospitals in China for Alport syndrome

No open trial on Alport syndrome lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Run the PubMed searchClinicalTrials.gov

Other diseases

IgA nephropathy

IgA 肾病

Led 3 of the 736 English-language PubMed papers on IgA nephropathy with an author in mainland China, 2021–2025: 0.4%.

Papers led
3
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 1120222023: 0020232024: 2220242025: 002025

25 hospitals in Beijing for IgA nephropathy300 hospitals in China for IgA nephropathy

No open trial on IgA nephropathy lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersNephrology

Run the PubMed searchClinicalTrials.gov

Other diseases

Primary biliary cholangitis

原发性胆汁性胆管炎

Led 1 of the 300 English-language PubMed papers on primary biliary cholangitis with an author in mainland China, 2021–2025: 0.3%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 0020242025: 112025

15 hospitals in Beijing for primary biliary cholangitis153 hospitals in China for primary biliary cholangitis

No open trial on primary biliary cholangitis lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Run the PubMed searchClinicalTrials.gov

Getting in touch

Name card to show staff or a driver

首都医科大学附属北京安贞医院

Beijing Anzhen Hospital

北京

Large hospitals often have several campuses. Confirm the campus with the hospital before travelling.

Inquiry letter in English and Chinese

Fill in the brackets, then send it through the contact options on the hospital's international office or official website. Nothing typed here leaves this device.

Records hospitals usually ask for

  • A recent summary or letter from the treating doctor
  • Pathology report
  • Scans (CT, MRI, PET) with their reports, and the images if possible
  • Treatments so far, with dates
  • Current medicines

What to do next

Talk with the treating doctorThis page can be shared with the treating doctor to discuss whether this team's work is relevant.
Check the team is still therePapers lag by months and doctors move. Look for the department on the hospital's own website.
Contact the hospital directlyUse the hospital's own contacts. Hospitals never pay us, and each hospital decides which patients it accepts.

Where these numbers come from

Papers

English-language PubMed papers whose first or last author lists this hospital as their first affiliation, 2021–2025. Definitions

Trials

ClinicalTrials.gov records naming this hospital as lead sponsor or site, as of 8 Nov 2026.

Identifiers and other names

ROR Wikidata
Beijing Anzhen Nanchong Hospital; Beijing Anzhen Nanchong Hospital of Capital Medical University; Capital Medical University Affiliated Beijing Anzhen Hospital; Beijing AnZhen Hospital; Beijing Anzhen Hospital Affiliated to the Capital Medical University; 北京市心肺血管疾病研究所

Suggest a correctionDownload the data